Evidence map›Paper›PMID 36314740›Full record

ArticleThe Journal of international medical research2022

Effects of discontinuation of antihypertensive drugs on frailty syndrome in outpatients: a 1-year prospectively designed retrospective chart-review pilot study.

Sho Hasegawa, Fumihiro Mizokami, Hiroki Mase, Yuji Hayakawa, Atsuya Shimizu, Yasumoto Matsui

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sho HasegawaDepartment of Pharmacy, National Center for Geriatrics and Gerontology, Obu, Japan.ORCID 0000-0003-1236-1623
Fumihiro MizokamiDepartment of Pharmacy, National Center for Geriatrics and Gerontology, Obu, Japan.
Hiroki MaseDepartment of Pharmacy, National Hospital Organization Sakakibara Hospital, Tsu, Japan.
Yuji HayakawaDepartment of Pharmacy, National Center for Geriatrics and Gerontology, Obu, Japan.
Atsuya ShimizuDepartment of Cardiology, National Center for Geriatrics and Gerontology, Obu, Japan.
Yasumoto MatsuiCenter for Frailty and Locomotive Syndrome, National Center for Geriatrics and Gerontology, Obu, Japan.
National Center for Geriatrics and Gerontology · JPSakakibara Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effects of discontinuing antihypertensive drugs on the characteristics of patients with frailty syndrome.

methodsThis prospective pilot study was conducted between March 2016 and July 2019. Among patients who visited the frailty clinic within this period, outpatients who received antihypertensive drugs at their first visit and were followed-up for about 1 year were enrolled. Participants who discontinued or continued antihypertensive drugs during 1 year of follow-up were classified into a discontinuation group or continuation group, respectively. Each domain in the Kihon checklist (KCL), fall risk score, short physical performance battery (SPPB) score, and skeletal muscle index (SMI) were assessed at the first visit and 1-year follow-up assessment, and were compared between the two groups.

resultsAmong 498 patients who attended the frailty clinic, 78 were enrolled (discontinuation group,

conclusionDiscontinuation of antihypertensive drugs may positively affect physical performance.

Indexed as

FrailtyAgedAntihypertensive AgentsFrail ElderlyGeriatric AssessmentHumansOutpatientsPilot ProjectsProspective StudiesRetrospective StudiesAntihypertensive Agentsdiscontinuation of antihypertensive drugsfall riskfrailty syndromeHypertensionKihon checklistphysical performance

Identifiers

PMID36314740
PMCPMC9629568
OpenAlexW4307690661

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.